QIAGEN NV's ticker is QGENXXXX and the CUSIP is N72482107. A total of 153 filers reported holding QIAGEN NV in Q2 2013. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $582,620,000 | -19.2% | 20,793 | -20.9% | 0.00% | 0.0% |
| Q3 2016 | $721,480,000 | +30.6% | 26,293 | +3.8% | 0.00% | +50.0% |
| Q2 2016 | $552,229,000 | -8.5% | 25,320 | -6.3% | 0.00% | -33.3% |
| Q1 2016 | $603,627,000 | -57.0% | 27,020 | -46.8% | 0.00% | 0.0% |
| Q4 2015 | $1,404,344,000 | +67.9% | 50,790 | +56.7% | 0.00% | +50.0% |
| Q3 2015 | $836,204,000 | -6.0% | 32,411 | -9.7% | 0.00% | 0.0% |
| Q2 2015 | $889,837,000 | +448.1% | 35,895 | +457.2% | 0.00% | – |
| Q1 2015 | $162,339,000 | +510.2% | 6,442 | +468.1% | 0.00% | – |
| Q4 2014 | $26,604,000 | -82.6% | 1,134 | -10.8% | 0.00% | – |
| Q3 2014 | $152,812,000 | -28.0% | 1,271 | +4.9% | 0.00% | – |
| Q2 2014 | $212,302,000 | -43.3% | 1,212 | -93.1% | 0.00% | – |
| Q3 2013 | $374,414,000 | +7.5% | 17,496 | 0.0% | 0.00% | – |
| Q2 2013 | $348,345,000 | – | 17,496 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Simcah Management LLC | 248,425 | $5,915,000 | 6.83% |
| Hardman Johnston Global Advisors LLC | 3,500,284 | $83,342,000 | 5.47% |
| Douglas C. Lane & Associates, Inc. | 1,892,425 | $45,059,000 | 1.50% |
| HARDING LOEVNER LP | 6,997,851 | $166,619,000 | 1.29% |
| CREDIT AGRICOLE S A | 7,703,028 | $183,409,000 | 0.76% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,781,076 | $42,407,000 | 0.73% |
| MANNING & NAPIER ADVISORS LLC | 6,290,930 | $149,784,000 | 0.68% |
| Orbimed Advisors | 1,927,000 | $45,882,000 | 0.67% |
| FIRST NEW YORK SECURITIES LLC /NY | 45,540 | $1,084,000 | 0.66% |
| PRIMECAP MANAGEMENT CO/CA/ | 19,385,944 | $461,579,000 | 0.56% |